Sugentech

수젠텍 · 253840

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$60.8M (₩83.9B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$6.8M

▼ −6.7% YoY

Operating profit · FY2025

−US$13.6M

Loss narrowed

Net income · FY2025

−US$17M

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$5.2M(₩7.1B)	US$7.3M(₩10.1B)	US$6.8M(₩9.4B)
Operating profit	−US$16.5M(−₩22.8B)	−US$16M(−₩22B)	−US$13.6M(−₩18.8B)
Net income	−US$12.6M(−₩17.4B)	−US$11.1M(−₩15.4B)	−US$17M(−₩23.5B)

Revenue

Operating profit

Net income

ROE

-30.7%

Debt/Eq

28.3%

Op. margin

-199.9%

Net margin

-249.5%

Rev. YoY

▼ −6.7%

Interactive price history isn't here yet. Would you use it?